TY  - GEN
AU  - Diaz-Beya, Marina
AU  - Brunet, S
AU  - Nomdedeu, J
AU  - Cordeiro, Anna
AU  - Tormo, M
AU  - Escoda, Lourdes
AU  - Ribera, J. M
AU  - Arnan, M
AU  - Heras, Inmaculada
AU  - Gallardo, David
AU  - Bargay Lleonart, Joan
AU  - Queipo de Llano, Maria Paz
AU  - Salamero, O
AU  - Marti, J. M
AU  - Sampol Mayol, Antonia
AU  - Pedro, C
AU  - Hoyos, M
AU  - Pratcorona, M
AU  - Castellano, JJ
AU  - Nomdedeu, M
AU  - Risueno, RM
AU  - Sierra, J
AU  - Monzo, M
AU  - Navarro, A
AU  - Esteve, Jordi
PY  - 2015
DO  - 10.1038/bcj.2015.76
SN  - 2044-5385
UR  - http://hdl.handle.net/20.500.12105/20149
AB  - Acute myeloid leukemia (AML) is a heterogeneous disease whose prognosis is mainly related to the biological risk conferred by cytogenetics and molecular profiling. In elderly patients (>= 60 years) with normal karyotype AML miR-3151 have been...
LA  - eng
PB  - Nature Publishing Group
KW  - Disease-Free Survival
KW  - Aged
KW  - Kaplan-Meier Estimate
KW  - Young Adult
KW  - Adult
KW  - Leukemia, Myeloid, Acute
KW  - Humans
KW  - Adolescent
KW  - Cytogenetic Analysis
KW  - Middle Aged
KW  - Prognosis
KW  - Transcriptome
KW  - Male
KW  - MicroRNAs
KW  - Neoplasm Proteins
KW  - Biomarkers, Tumor
KW  - Female
KW  - Risk Factors
KW  - Proportional Hazards Models
TI  - The expression level of BAALC-associated microRNA miR-3151 is an independent prognostic factor in younger patients with cytogenetic intermediate-risk acute myeloid leukemia
TY  - research article
ER  -